Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
NCT07568574Enrolling by invitation
- Sponsor
- Enhanced Emirates
- Start
- Mar 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Enhanced Emirates. Primary endpoints: Incidence and severity of Treatment-related adverse events at 5.5 years and Proportion of participants who discontinue PES due to TRAEs at 5.5 years. Started Mar 2026; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT07568574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568574.